Feedback / Questions
sabirnetug IV (ACU193 IV) - Acumen Pharma
Undisclosed Enhanced Brain Delivery therapy - Acumen Pharma, JCR Pharma
https://www.manilatimes.net/2026/05/12/tmt-newswire/globenewswire/acumen-pharmaceuticals-reports-first-quarter-2026-financial-results-and-business-highlights/2341551/amp
May 12, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next